COVID-19 patients had unique hyperinflammatory signatures across all types of peripheral blood immune cells, particularly increases in TNF- and IL-1β-driven inflammatory responses, whereas IFN responses were dominant in severe influenza patients. The gene discussed is IL1B; the disease is COVID-19.